New leukemia treatment uses disabled HIV to save girl’s life

A new leukemia treatment, which showed success in adults during its debut, is now making the same headway in children, states a report from the CBS Evening News. The process uses disabled human immunodeficiency virus (HIV)–the virus that causes AIDS–to modify T-cells in a way which allows them to track and target leukemia cells.

FDA Approves Vidaza for Rare Pediatric Blood Cancer

New molecular subset of pediatric liver cancer identified

Frozen testicular tissue still viable after two decades

Study identifies potential target for treating childhood blood cancer

RAI Treatment in DTC Survivors Associated With Increased Risk of Other Cancers

AYA cancer survivors at higher risk for death due to second primary cancers

Immunotherapy for kids: An option for childhood liver cancer?

Biological pathways found that drive genomic changes and bone metastasis in Ewing Sarcoma

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

We may know why some childhood cancers resolve on their own

Recent Posts